Clinical and Translational Medicine (Jun 2024)

Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor

  • Zi‐Yang Shi,
  • Ying Fang,
  • Peng‐Peng Xu,
  • Hong‐Mei Yi,
  • Jian‐Feng Li,
  • Yan Dong,
  • Yue Zhu,
  • Meng‐Ke Liu,
  • Di Fu,
  • Shuo Wang,
  • Qing Shi,
  • Rong Shen,
  • Hui‐Juan Zhong,
  • Chao‐Fu Wang,
  • Shu Cheng,
  • Li Wang,
  • Feng Liu,
  • Wei‐Li Zhao

DOI
https://doi.org/10.1002/ctm2.1691
Journal volume & issue
Vol. 14, no. 6
pp. n/a – n/a

Abstract

Read online

No abstracts available.